IHAM
Integral Health Asset Management’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.86M | Sell |
100,000
-50,000
| -33% | -$2.43M | 0.45% | 56 |
|
|
2025
Q1 | $5.1M | Buy |
+150,000
| New | +$5.1M | 0.54% | 46 |
|
|
2024
Q4 | – | Sell |
-150,000
| Closed | -$7.05M | – | 84 |
|
|
2024
Q3 | $7.05M | Hold |
150,000
| – | – | 0.79% | 32 |
|
|
2024
Q2 | $8.1M | Sell |
150,000
-70,000
| -32% | -$3.78M | 0.77% | 39 |
|
|
2024
Q1 | $15M | Buy |
+220,000
| New | +$15M | 1.39% | 28 |
|
|
2023
Q4 | – | Sell |
-275,000
| Closed | -$12.5M | – | 74 |
|
|
2023
Q3 | $12.5M | Buy |
275,000
+175,000
| +175% | +$7.94M | 1.73% | 20 |
|
|
2023
Q2 | $5.61M | Hold |
100,000
| – | – | 0.7% | 50 |
|
|
2023
Q1 | $4.52M | Buy |
+100,000
| New | +$4.52M | 0.91% | 43 |
|
|
2022
Q4 | – | Sell |
-220,000
| Closed | -$14.4M | – | 69 |
|
|
2022
Q3 | $14.4M | Buy |
220,000
+139,990
| +175% | +$9.15M | 2.79% | 8 |
|
|
2022
Q2 | $4.86M | Sell |
80,010
-39,990
| -33% | -$2.43M | 1% | 35 |
|
|
2022
Q1 | $7.53M | Buy |
+120,000
| New | +$7.53M | 1.96% | 17 |
|